Crucell N.V.
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
17 aug 2010 - 07:39
Statutaire naam
Crucell N.V.
Titel
Crucell Reports Record Revenues in Second Quarter 2010
Bericht
Total revenues and other operating income of €128.6 million, a 63% growth compared to the same period in 2009 (€78.7 million).
Strong sales of Quinvaxem® drive record second quarter revenues.
Operating profit of €13.1 million compared to €3.2 million in Q2 2009.
Net profit of €9.2 million compared to net loss of €1.8 million in Q2 2009.
Undiluted EPS of €0.11 compared to minus €0.03 in the same quarter of 2009.
2010 Revenue Guidance Increased
As a result of strong sales in the first half of the year, we expect total revenues and other operating income for the full year to exceed 2009 levels.
Datum laatste update: 12 februari 2025